Sort by
Refine Your Search
-
Category
-
Field
-
and in vivo model systems, applying multiple omics methods. You will be working with clinical samples, method development and several molecular biology techniques, especially PCR and sequencing as
-
systems, or network analysis. Experience with methods for causal inference, or modelling of biological systems is also considered a merit, along with prior work involving large-scale sequencing data such as
-
sequencing and synthesis to design useful cell behaviors. The scope of this project is to combine multi-gene control technology and computer algorithms to develop a foundational discovery platform for future
-
the Karolinska Neuroimmunology and Multiple Sclerosis (KNIMS) division which gathers around 40 researchers working on different aspects of the pathogenesis of Multiple Sclerosis (MS) and other neurodegenerative
-
cellular techniques, such as bulk and single-cell RNA sequencing, spatial transcriptomics, immunohistochemistry, immunoprecipitation, RNA-pull down, ChIP-seq, or CRISPR/Cas9-based gene editing etc. The exact
-
holder will have the opportunity to gain qualifications are: Data collection and curation. Whole genome sequence and annotation (coding and non-coding) from diverse plant species have been prepared, while
-
both in vivo and in vitro, sequenced the genome of the Iberian newt, established stable transgenesis, and created genome-edited newts. Harnessing these technological developments, the group is combining
-
responsibilities include bioinformatics analyses with a strong focus on single-cell RNA sequencing and next-generation single-cell barcode lineage tracing, as well as the interpretation of complex biological
-
research is based on large and high-dimensional datasets across multiple modalities, including molecular, clinical and histopathology imaging data. Our computational pathology research is based
-
diabetes, including collaborations with the Rorsman and Rosengren labs Access to unique human tissue samples from multiple sites across Europe and Canada Opportunities for collaboration with Sahlgrenska